Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Effects of Spirulina platensis supplementation on lipid profile in HIV–infected antiretroviral naïve patients in Yaounde - Cameroon: a randomized trial study
2014
Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK
2019
An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia
2014
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Microalgae in modern cancer therapy: Current knowledge
2018 Standout
Oxidative stress, aging, and diseases
2018 Standout
Towards better clinical prediction models: seven steps for development and an ABCD for validation
2014 Standout
Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis
2013
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
2009
Phospholipase A2 inhibition and atherosclerotic vascular disease: prospects for targeting secretory and lipoprotein-associated phospholipase A2 enzymes
2010
Phospholipase A2s: Developing drug targets for atherosclerosis
2010
Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients
2010
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial
2009
Microparticles in atrial fibrillation: A link between cell activation or apoptosis, tissue remodelling and thrombogenicity
2013
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Future Role for Selective Phospholipase A2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease
2009
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
2010
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis
2010
The global burden of multiple chronic conditions: A narrative review
2018 Standout
The synergistic inhibition of atherogenesis in apoE−/− mice between pravastatin and the sPLA2 inhibitor varespladib (A-002)
2008
Systemic treatment of hepatocellular carcinoma: An EASL position paper
2021
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
2018 Standout
Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension
2011
Tumor angiogenesis and novel antiangiogenic strategies
2009
Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
2009
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review
2010
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Drug-related hypertension and resistance to antihypertensive treatment
2011
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
The acute effect of percutaneous mitral balloon valvuloplasty on atrial electromechanical delay and P-wave dispersion in patients with mitral stenosis
2012
HIV infection and cardiovascular disease
2014
Microparticles: Key Protagonists in Cardiovascular Disorders
2010
Distinct Polysaccharide Utilization Determines Interspecies Competition between Intestinal Prevotella spp.
2020 StandoutNobel
Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
2013
Hepatocellular carcinoma
2022 Standout
An Algorithm for the Management of Hypertension in the Setting of Vascular Endothelial Growth Factor Signaling Inhibition
2011
Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs
2016
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
2018 Standout
Incidence and risk of hypertension with a novel multi‐targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta‐analysis
2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Biochemistry and Physiology of Mammalian Secreted Phospholipases A2
2008
Metabolic Syndrome and Carotid Intima-Media Thickness in Young Adults: Roles of Apolipoprotein B, Apolipoprotein A-I, C-Reactive Protein, and Secretory Phospholipase A2: The Cardiovascular Risk in Young Finns Study
2010
Novel biomarkers for cardiovascular risk prediction.
2017
Mendelian randomisation applied to drug development in cardiovascular disease: a review
2014
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
2010
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START ) trial
2015
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Combination therapy in combating cancer
2017 Standout
Cancer Therapy–Related Cardiac Dysfunction and Heart Failure
2016
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Targeted Cancer Therapy: Giving Histone Deacetylase Inhibitors All They Need To Succeed
2012
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Cellular Mechanisms Underlying the Formation of Circulating Microparticles
2010
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Cardiovascular toxicities associated with immune checkpoint inhibitors
2019
Works of Stéphane Éderhy being referenced
Decrease in Left Atrium Volume after Successful Balloon Mitral Valvuloplasty: An Echocardiographic and Hemodynamic Study
2010
QT interval prolongation among patients treated with angiogenesis inhibitors
2009
Should all patients with non-valvular atrial fibrillation be anticoagulated?
2010
Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism
2010
HIV and Coronary Heart Disease
2013
Effectiveness of Screening for Abdominal Aortic Aneurysm During Echocardiography
2014
Levels of Circulating Procoagulant Microparticles in Nonvalvular Atrial Fibrillation
2007
Management of hypertension in angiogenesis inhibitor-treated patients
2009
Frequency and management of troponin I elevation in patients treated with molecular targeted therapies in phase I trials
2010
Circulating Secretory Phospholipase A2 Activity and Risk of Incident Coronary Events in Healthy Men and Women
2007
Myocarditis in the Setting of Cancer Therapeutics
2019
Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors
2018
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
2020